Puts Purchased on Gen-Probe Incorporated (GPRO)

Shares of Gen-Probe Incorporated

are higher on the session by 0.65%, currently trading at $48.37. The stock has been moving largely higher over the past two months and is currently trading above the 18, 50, and 200-day moving averages. Options traders are buying protection on the name today. A short while ago the November $45.00 put was purchased 1,000 times, on the offer, on open interest of 403 contracts. This signals new positioning on the name. Overall put volume is now running at 14.66x the daily average, 93% on the offer. Gen-Probe Incorporated is engaged in the development, manufacture and marketing of nucleic acid tests used to diagnose human diseases and screening donated human blood. It also markets a range of products to detect infectious microorganisms, including those causing sexually transmitted diseases, tuberculosis, strep throat, and other infections.